Back
Alnylam Pharmaceuticals Stock Predictions
Sponsored
ALNY
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
285.72
Seasonality Move:
13.96%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.Alnylam Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 41.7% based on the past 20 years of stock performance.
- Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $284.69. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. - ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 41.7% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
- Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
304.39
52-Week Low:
141.98
Prediction Charts
Market Cap:
36.55B
Price in USD:
284.69
Volume:
610.01K
Beta:
1.20
Technical Analysis
SMA50:
274.65
SMA100:
252.43
SMA200:
204.43
52-Wk Change:
87.59%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company. -
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 284.69 USD today. -
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-9 | 272.00 | 270.89 | 273.23 | 269.00 |
Oct-10 | 270.50 | 278.62 | 282.45 | 269.00 |
Oct-11 | 278.80 | 284.32 | 286.02 | 278.26 |
Oct-14 | 284.09 | 283.32 | 285.72 | 280.82 |
Oct-15 | 284.85 | 287.43 | 289.67 | 283.75 |
Oct-16 | 286.39 | 300.55 | 301.87 | 286.39 |
Oct-18 | 296.01 | 295.93 | 298.94 | 295.51 |
Oct-21 | 294.33 | 292.01 | 295.39 | 288.34 |
Oct-22 | 292.10 | 296.48 | 297.51 | 291.90 |
Oct-23 | 296.48 | 294.87 | 299.17 | 292.20 |
Oct-24 | 293.92 | 293.69 | 301.05 | 293.45 |
Oct-25 | 293.69 | 284.86 | 293.74 | 283.78 |
Oct-28 | 288.35 | 286.91 | 290.94 | 285.85 |
Oct-29 | 285.93 | 284.69 | 287.02 | 282.22 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.75 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.